ARQT reports inducement grants under Nasdaq Rule 5635(c)(4)
Arcutis Biotherapeutics (ARQT) reported inducement grants under Nasdaq Listing Rule 5635(c)(4).
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.